We were all expecting it and here it is: the famous second epidemic wave of coronavirus is hitting France this Fall 2020. To face the exponential increase in infections, French people could not escape another nationwide lockdown. But this time, unlike the first wave that took everyone by surprise, new means are available to fight against the epidemic.
As for screenings, the arrival of the quick “antigenic” tests in France could enable to improve detecting new coronavirus cases. The flaw is that even though they deliver results in 15 minutes, they are less reliable than PCR tests – longer – we had so far. According to the ARS, their reliability is under 60%.
So, should you get a quicker but less reliable test or a more reliable but longer test? Depending on your situation, here is what screening method you should get.
Quick “antigenic” tests are recommended if:
- You show no symptoms
- You show symptoms for less than 4 days, you are under 65, and you are not subject to a risk factor likely to lead to severe coronavirus
- You are no contact case
- You have not been detected in a cluster
More reliable PCR tests are recommended if:
- You are over 65 years old and show symptoms
- You show symptoms and are part of people likely to be at risk and get severe coronavirus
- You are a contact case
- You are related to a cluster
More on the topic:
Coronavirus: antigenic tests, everything you need to know about these quick screenings
To face the second coronavirus epidemic wave, new means are available in order to make screenings easier. The arrival of antigenic screen tests could be a game-changer: these quick screenings – even though less reliable than PCR tests – enable to get results within 15 minutes. Here is everything you need to know about them.
Coronavirus: specifications on people at risk and vulnerable
Now, we know more about people the most likely to catch and develop a serious kind of coronavirus disease. In addition to elderly people, discover who really has to protect themselves from any interaction and stay home.